Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Has announcements × Gastrointestinal × Clear all

Phase

Phase 3 29 Phase 2 16 Phase 1/2 8 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 5 Lymphoid 5 Myeloid 4 Other solid neoplasm 3 Thoracic 2 Dermatologic 2 CNS 2 Tumor-Agnostic 1 Sarcoma 1 Plasma cell 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02508532 2022-06-21

(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors

Blueprint Medicines Corporation

Phase 1 Completed

250 enrolled 36 charts 2 FDA

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡